1 April 2023 false No description of principal activity Taxfiler 2024.4 11058429business:PrivateLimitedCompanyLtd2023-04-012024-03-31 110584292023-03-31 110584292023-04-012024-03-31 11058429business:AuditExempt-NoAccountantsReport2023-04-012024-03-31 11058429business:FilletedAccounts2023-04-012024-03-31 110584292024-03-31 11058429business:Director12023-04-012024-03-31 11058429business:RegisteredOffice2023-04-012024-03-31 110584292023-03-31 11058429core:WithinOneYear2024-03-31 11058429core:WithinOneYear2023-03-31 11058429core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 11058429core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 11058429core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 11058429core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 11058429core:PreviouslyStatedAmount2024-03-31 11058429core:PreviouslyStatedAmount2023-03-31 11058429business:SmallEntities2023-04-012024-03-31 11058429countries:EnglandWales2023-04-012024-03-31 11058429core:FurnitureFittings2023-03-31 11058429core:FurnitureFittings2023-04-012024-03-31 11058429core:FurnitureFittings2024-03-31 11058429core:AdditionsToInvestments2024-03-31 11058429core:RevaluationsIncreaseDecreaseInInvestments2024-03-31 110584292022-04-012023-03-31 iso4217:GBP xbrli:pure
Company Registration No. 11058429 (England and Wales)
Schroeder Therapeutics Ltd Unaudited accounts for the year ended 31 March 2024
Schroeder Therapeutics Ltd Unaudited accounts Contents
Page
- 2 -
Schroeder Therapeutics Ltd Company Information for the year ended 31 March 2024
Director
Dr Tania Schroeder
Company Number
11058429 (England and Wales)
Registered Office
Capshire Uk Llp Castle Court 41 London Road, Reigate England RH2 9RJ UNITED KINGDOM
- 3 -
Schroeder Therapeutics Ltd Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
28,000 
20,603 
Investments
62,398 
60,670 
90,398 
81,273 
Current assets
Inventories
268 
321 
Debtors
1,797 
3,954 
Cash at bank and in hand
581 
1,928 
2,646 
6,203 
Creditors: amounts falling due within one year
(6,842)
(5,160)
Net current (liabilities)/assets
(4,196)
1,043 
Net assets
86,202 
82,316 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
85,202 
81,316 
Shareholders' funds
86,202 
82,316 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 9 May 2024 and were signed on its behalf by
Dr Tania Schroeder Director Company Registration No. 11058429
- 4 -
Schroeder Therapeutics Ltd Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
Schroeder Therapeutics Ltd is a private company, limited by shares, registered in England and Wales, registration number 11058429. The registered office is Capshire Uk Llp Castle Court, 41 London Road, Reigate, England, RH2 9RJ, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Fixtures & fittings 
£ 
Cost or valuation
At cost 
At 1 April 2023
104,609 
Additions
35,000 
At 31 March 2024
139,609 
Depreciation
At 1 April 2023
84,006 
Charge for the year
27,603 
At 31 March 2024
111,609 
Net book value
At 31 March 2024
28,000 
At 31 March 2023
20,603 
- 5 -
Schroeder Therapeutics Ltd Notes to the Accounts for the year ended 31 March 2024
5
Investments
Other investments 
£ 
Valuation at 1 April 2023
60,670 
Additions
5,629 
Fair value adjustments
(3,901)
Valuation at 31 March 2024
62,398 
6
Inventories
2024 
2023 
£ 
£ 
Raw materials
268 
321 
268 
321 
Stock is measured at lower of cost or net realizable value
7
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
797 
1,454 
Accrued income and prepayments
- 
1,500 
Other debtors
1,000 
1,000 
1,797 
3,954 
8
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
5,402 
2,579 
Loans from directors
- 
1,321 
Accruals
1,440 
1,260 
6,842 
5,160 
9
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -